MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    The 360° Turn Test as a Single and Dual Task in people with Parkinson’s disease and cognitively unimpaired controls

    M. Lindh-Rengifo, S. Fors, S. Palmqvist, E. Stomrud, N. Mattsson-Carlgren, M. Nilsson (Lund, Sweden)

    Objective: To investigate the effects of adding a cognitive subtraction task on the duration of the 360° turn test, and to compare the performance between…
  • 2026 International Congress

    Micrographia is an Early Abnormality in CAR-T Cell Therapy-Associated ICANS

    J. Patino, S. Marcucci, K. Duque, M. Chirra, A. Suppa, A. Espay, A. Zabeti, E. Faber, L. Marsili (Cincinnati, USA)

    Objective: To better characterize the underlying movement disorders and cognitive deficits that manifest as dysgraphia in immune effector cell-associated neurotoxicity syndrome (ICANS), and to identify…
  • 2026 International Congress

    Amyloid Burden in the Precuneus and Posterior Cingulate Gyrus Is Associated With Cognitive Function and White Matter Microstructure in Lewy Body Dementia

    H. Takeshige-Amano, N. Nishikawa, M. Osawa, H. Okada, D. Kamiyama, K. Onuki, S. Takemoto, K. Takabayashi, K. Kamagata, K. Murakami, T. Kato, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: To investigate the relationship between amyloid burden measured by PET and white matter microstructural alterations assessed by advanced diffusion MRI in individuals with Parkinson’s…
  • 2026 International Congress

    Clinical-Genealogical Analysis of Parkinson’s Disease

    M. Ibodullaeva, R. Matmurodov, KH. Daminova (Tashkent, Uzbekistan)

    Objective: The aim of the study is to investigate the clinical and genealogical features of Parkinson's disease. Background: More than 90% of Parkinson's disease (PD)…
  • 2026 International Congress

    Neuroprotective Effects of Emodin Against Rotenone-Induced Parkinsonism Through Regulation of SIRT1-Mediated Inflammasome and Nrf2 Pathways

    A. Kumar (Prayagraj, India)

    Objective: This study aimed to investigate the neuroprotective potential of emodin in a rotenone-induced PD model and to elucidate its underlying molecular mechanisms focusing on…
  • 2026 International Congress

    Bilateral Hemifacial Spasm Caused by In-Ear Hearing Aids

    J. Thomas, N. Schuck, K. Mangipudi (Jacksonville, USA)

    Objective: To identify uncommon causes of hemifacial spasm, such as from in-ear hearing aids. Background: Hemifacial spasm is an abnormal, involuntary contraction of the facial…
  • 2026 International Congress

    Baseline Factors Associated with Sublingual Apomorphine Film Maintenance Dose

    J. Kassubek, J. Schwarz, L. López Manzanares, J. Reis, H. C. Brigas, C. Denecke-Muhr, J. Holenz (Ulm, Germany)

    Objective: To identify baseline demographic and clinical factors associated with the final titrated dose of sublingual apomorphine (SL-APO) in patients with Parkinson’s disease (PD) experiencing…
  • 2026 International Congress

    Synergistic Impact of Plasma Neurofilament Light Chain and Neuroimaging Deficits on Cognitive Decline in Prodromal Lewy Body Disease

    K. Hiraga, D. Tamakoshi, T. Fukushima, Y. Saito, K. Fuse, T. Uematsu, T. Tsuboi, M. Sato, K. Yokoi, K. Suzuki, Y. Arahata, Y. Washimi, M. Yamamoto, H. Shimizu, M. Wakai, H. Tatebe, T. Tokuda, A. Nakamura, S. Niida, M. Katsuno (Nagoya, Japan)

    Objective: To assess the synergy between neuroimaging deficits and plasma biomarkers in predicting longitudinal cognitive and motor progression in individuals at high risk for prodromal…
  • 2026 International Congress

    “Unexplained” Chorea Explained by Neuronal Antibodies: A Dutch Cohort Study

    J. Kerstens, J. de Vries, M. van Coevorden-Hameete, S. Franken, M. Nagtzaam, S. Veenbergen, E. Verhagen, P. Sillevis Smitt, S. de Bot, M. Oosterloo, A. Boon, M. Titulaer (Rotterdam, Netherlands)

    Objective: To identify neuronal antibodies in patients with unexplained chorea. Background: In recent years, autoimmune causes of chorea are increasingly recognized and the number of…
  • 2026 International Congress

    Risk of Serotonin Syndrome in the Combined Use of Selective Monoamine Oxidase B Inhibitors and Serotonin-acting Antidepressants

    RWH. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)

    Objective: We aim to determine the risk of serotonin syndrome with selective monoamine oxidase B inhibitors (MAO-Bi) use, especially when combined with serotonin-acting antidepressants. Background:…
  • « Previous Page
  • 1
  • …
  • 172
  • 173
  • 174
  • 175
  • 176
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley